Walgreens Thinks the Grass Is Greener in Private Equity: What Happens Next for Retail, Beauty, and Pharmacy?

Walgreens Boots Alliance is going private in a $10 billion deal with Sycamore Partners. The move is framed as a way to restructure away from public market scrutiny, but the implications extend well beyond ownership. With Boots, its U.K.-based beauty and pharmacy chain, also in the mix, the deal is likely to reverberate through adjacent categories and international markets.

A Shift From Public Markets to Private Mandates

Sycamore will become the latest private equity firm to take control of a top-20 U.S. retailer. Walgreens has struggled with declining foot traffic, increased competition, and an overstretched store base. The company had already committed to $1 billion in cost cuts and a reduction of up to 1,200 locations. Going private will ease quarterly reporting pressures, but introduces another set of incentives focused on value extraction.

Boots is also under pressure. Employees are bracing for job cuts and store closures as its parent company realigns its capital structure. While Walgreens has not confirmed plans to spin off or reposition Boots, analysts and employees are preparing for changes that may follow the transaction.

Joann, Hudson’s Bay, and At Home: Recent Case Studies

Walgreens is joining a wave of retailers that have turned to private ownership for operational breathing room. Joann re-entered public markets in 2021 after being owned by Leonard Green & Partners. Just three years later, it filed for bankruptcy and was reacquired by the same firm in a pre-packaged restructuring deal.

Hudson’s Bay Company was taken private in 2020 by a consortium led by executive chairman Richard Baker. After spinning off Saks.com and attempting to modernize its assets, the company filed for creditor protection in early 2025 and began winding down its Canadian department store business. Its 355-year legacy concluded not with a splashy exit, but a series of concessions to reality.

At Home was acquired by Hellman & Friedman in 2021, riding high on pandemic-era home décor demand. It recently filed for Chapter 11. It cited tariffs and weak consumer spending as drivers of its liquidity crisis, having missed an interest payment in May, then entered forbearance with lenders. Its restructuring support agreement calls for eliminating nearly all of its $2 billion debt and providing $200 million in new capital, with an initial closure of 26 stores by September. Lenders are expected to convert most debt into ownership, while the company remains in operations during restructuring.

These are just a few of examples that reflect the range of outcomes under private ownership. Some firms exit stronger, others stall. A few vanish entirely.

Strategic Implications for the Beauty Category

Boots is a category leader in U.K. mass beauty. Its future will be shaped by how Sycamore chooses to manage its capital, store footprint, and private-label innovation. If Boots sees cuts in investment or loses control of its identity, beauty brands may seek more stable partners. This shift would coincide with Ulta Beauty’s planned entry into the U.K. market, an expansion that may have once seemed audacious but now looks strategically timed.

The reallocation of shelf space, marketing budgets, and store labor has already begun in anticipation. If Boots is forced to compete on thinner margins or under constrained leadership, Ulta may find less resistance than expected.

Pressures on Pharmacy and Health Retail

On the pharmacy side, Walgreens is not alone in navigating structural headwinds. CVS, Walmart, and Amazon have each moved more aggressively into healthcare services, leaving Walgreens to play catch-up in delivery models and in-store care.

Private ownership may allow Walgreens to move faster in modernizing its offerings, but it will also require tighter returns on capital deployed. There will be little room for experimentation. Walgreens is now the largest PE-backed retailer in the United States by store count, making it a closely watched example of whether scale and leverage can coexist with reinvention.

Ownership as Strategy, Not Structure

Walgreens going private may look like a retreat from public failure, but it is also a strategic pivot. Ownership structure increasingly reflects corporate intent. Going private is not the end of scrutiny. It is a shift in who is watching and what they expect.

For a category like beauty, which thrives on consistency and trust, the introduction of leveraged incentives into a foundational retailer creates instability. For pharmacy, the concern is speed. Walgreens has struggled to keep pace and now must do so without the safety net of public equity.

The question isn't whether private equity can fix Walgreens. It's whether the conditions that drove it private in the first place will allow for the kind of reinvention retail needs most.